Skip to main content

RT @uptoTate: Treatment with MTX in early CCP+ RA thought to be effective in slowing disease however StopRA study did no

Social Author Name
Dr. Rachel Tate
Tweet Content
Treatment with MTX in early CCP+ RA thought to be effective in slowing disease however StopRA study did not show a difference between HCQ and PBO in patients. We need to know more about HCQ vs MTX in this space! #RNL2023 @RheumNow https://t.co/7asmvVfXiC
Show on Archive Page
On
Display in Search Results
On
PDQ
Off